Safety and efficacy of oral icotrokinra for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.

Front Immunol · 2026 · PMC13002440 · PMID 41869308

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The trim-and-fill analysis detected no evidence of publication bias, and the pooled estimate remained highly significant ( Supplementary Table 5 ; Supplementary Figure 10 ). 3.4.2.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.